A comparative analysis of current blood pressure management guidelines in people with and without diabetes. Issue 11 (10th July 2020)

• Record Type: Journal Article
• Authors: Xu, Yu; Wu, Shujing; Niu, Jingya; Li, Mian; Lu, Jieli; Wang, Weiqing; He, Jiang; Solomon, Henry A.; Bi, Yufang; Ning, Guang
• Is Part Of: Journal of diabetes. Volume 12:Issue 11(2020)
• Page Start: 781
• Page End: 790
• Publication Date: 2020-07-10
• Subjects: blood pressure management guidelines -- diabetes -- hypertension; 血压管理指南 -- 糖尿病 -- 高血压; Diabetes -- Periodicals; 618.3646005
• DOI: 10.1111/1753-0407.13071
• Languages: English
• ISSNs: 1753-0393

Abstract

Abstract: Hypertension is the leading global risk factor for cardiovascular disease and premature death. Recommendations from current guidelines of blood pressure (BP) management differ in many ways; therefore, we did an overview and comparative analysis of major clinical guidelines of BP management in people with and without diabetes, including the definition and classification of hypertension, initiation of antihypertensive drug therapy, BP control targets, and antihypertensive treatment strategies. BP management in patients with diabetes was discussed in great detail using both hypertension and diabetes guidelines. We conclude that high‐level evidence from high‐quality clinical studies is urgently needed to settle uncertainties on BP management recommendations. Abstract : Highlights Recommendations from current guidelines of blood pressure (BP) management differ a great deal, especially BP thresholds for initiation of antihypertensive drug therapy and BP treatment targets in people with and without diabetes. High‐level evidence from high‐quality clinical studies is urgently needed to settle uncertainties on BP management recommendations. 摘要: 高血压是全球心血管疾病和过早死亡的主要危险因素。当前的血压管理指南推荐意见在许多方面存在差异，因此我们对糖尿病与非糖尿病人群主要血压管理临床指南进行了概述及比较分析，包括高血压的定义和分类，降压药物干预 启动阈值 ，血压控制目标以及降压治疗策略。对于高血压合并糖尿病患者，我们纳入高血压及糖尿病相关指南进行详细讨论。我们得出结论:急需高质量临床研究提供高水平证据来解决血压管理指南推荐意见的不确定性。